Search

Your search keyword '"Gjerdrum, Lise Mette Rahbek"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Gjerdrum, Lise Mette Rahbek" Remove constraint Author: "Gjerdrum, Lise Mette Rahbek" Search Limiters Full Text Remove constraint Search Limiters: Full Text
28 results on '"Gjerdrum, Lise Mette Rahbek"'

Search Results

1. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma

2. Topical Neuropeptide Y for Ischemic Skin Wounds

3. Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma

7. Combination Therapy with Ruxolitinib and Interferon in Newly Diagnosed Patients with Polycythemia Vera

8. Concomitant Inhibition of FASN and SREBP Provides a Promising Therapy for CTCL

9. The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab‐containing line of therapy

10. The real-world outcomes of multiple myeloma patients treated with daratumumab

13. Spatial expression of metallothionein, matrix metalloproteinase-1 and Ki-67 in human epidermal wounds treated with zinc and determined by quantitative immunohistochemistry: A randomised double-blind trial

14. Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms

15. Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3

16. The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab‐containing line of therapy.

17. Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study

18. MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas

20. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

21. The Clinical Course and Life Expectancy of Patients with Multiple Myeloma Who Discontinue Their First Daratumumab-Containing Line of Therapy

22. Role of B-cells in Mycosis Fungoides.

23. Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark.

24. Orbital precursor B-lymphoblastic lymphoma involving the extraocular muscles in a 56-year-old male and a review of the literature.

25. Different Immunological Phenotypes Associated with Preserved CD4+ T Cell Counts in HIV-Infected Controllers and Viremic Long Term Non-Progressors

26. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma

27. Combination Therapy with Ruxolitinib and Pegylated Interferon-alpha2a in Newly Diagnosed Patients with Polycythemia Vera.

28. Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma.

Catalog

Books, media, physical & digital resources